Frequently Asked Questions
What is Sun Pharmaceutical Industries Ltd?
Sun Pharmaceutical Industries Limited is an India-based specialty generic pharmaceutical company. The Company is engaged in the business of manufacturing, developing and marketing a wide range of branded and generic formulation and active pharmaceutical ingredients (APIs). It produces a comprehensive, diverse and complementary portfolio of generic and specialty medicines targeting a wide spectrum of chronic and acute treatments. The Company's vertically integrated network enables it to produce a wide range of pharmaceuticals, including oncology, hormones, peptides, and steroidal drugs. The Company also has a product portfolio in RoW markets, including injectables, hospital products and retail products. It offers a variety of dosage forms, including orals, creams, ointments, injectables, sprays, and liquids. Its marketed specialty portfolio includes Ilumya/ Ilumetri, Winlevi, Levulan Kerastick + BLU-U, Absorica LD, Odomzo, Cequa, Bromsite, Xelpros, Yonsa, Sezaby and Sprinkle portfolio.
What is CAGR?
CAGR stands for Compound Annual Growth Rate. In the stock market, it's a useful metric to measure the compound annual growth rate of an investment over a specific period of time, assuming the profits are reinvested at the end of each year. CAGR shows how much an investment grows each year on average.
What is the 3 year, 5 year and 10 Year CAGR (annualized return) of Sun Pharmaceutical Industries Ltd?
CAGR (Compound Annual Growth Rate) of Sun Pharmaceutical Industries Ltd is as follows:
- 3 Year CAGR: 19.98%
- 5 Year CAGR: 25.54%
- 10 Year CAGR: 6.15%
What is the 1 year return of Sun Pharmaceutical Industries Ltd?
In the past 1 year, Sun Pharmaceutical Industries Ltd has given a return of -14.63%.
How often the data is updated on this page?
The Current Market Price (CMP) and CAGR data are updated every 15 minutes during market hours. However, the current month's and current year's returns are updated daily after the market closes.